BVMF/T2ND34 (BVMF/T2ND34)

Brazil Stock Exchange: BVMF/T2ND34 · BRL

R$6.90

+0.10 (+1.5%)· Recorded snapshot

Market cap	7.4B
Revenue (ttm)	5.4B
Net income (ttm)	-328M
EPS (ttm)	-R$0.28
Volume	263

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.4B
Net income (ttm): -328M
EPS (ttm): -R$0.28
Market cap: 7.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11.9P50 16.6P75 25.6

Trailing P/En/a

P25 15.1P50 22.9P75 38.5

ROE-48

P25 2.7P50 10.8P75 20.1

ROIC-12.1

P25 6.3P50 12.1P75 21.3

Benchmarks · 1M

All BVMF/T2ND34 indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-05
Employees	2,500
Employees change	-150
Employees growth	-5.66%
Enterprise value	BRL 8.9B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	December
Founded	2006
Industry	Medical Devices
Is primary listing	No
ISIN number	BRT2NDBDR007
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	BRL 7.4B
Next earnings date	2026-11-05
Price	BRL 6.90
Price currency	BRL
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-28
Symbol	bvmf/T2ND34
Website	https://www.tandemdiabetes.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-3.99%
EV/Sales	1.59x
FCF / EV yield	-1.55%
FCF yield	-1.87%
P/B ratio	10.89x
P/S ratio	1.36x
Price / tangible book value	10.89x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-4.13%
EBITDA margin	-2.4%
Gross margin	56.01%
Operating margin	-4.13%
Pretax margin	-5.86%
Profit margin	-6.08%
Profit per employee	BRL -131,209
Revenue per employee	BRL 2.2M
ROA	-2.65%
ROA (5Y)	-4.54%
ROCE	-4.77%
ROE	-48.03%
ROE (5Y)	-41.61%
ROIC	-12.1%
ROIC (5Y)	-25.83%
SBC / revenue	6.98%
Tax / revenue	0.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	10.82%
Gross profit growth (Q)	15.04%
Gross profit growth 3Y	12.97%
Gross profit growth 5Y	12.65%
Net income growth quarters	2
Net income growth years	0
Revenue growth	3.96%
Revenue growth (Q)	5.77%
Revenue growth (QoQ)	2.97%
Revenue growth 10Y	28.05%
Revenue growth 3Y	9.63%
Revenue growth 5Y	11.48%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -109.3M
Depreciation and amortization	BRL 96M
EBIT	BRL -222.7M
EBITDA	BRL -129.7M
EPS	BRL -0.28
Financing cash flow	BRL 1.4B
Free cash flow	BRL -137.9M
Free cash flow minus SBC	BRL -514.3M
Gross profit	BRL 3B
Income taxes	BRL 12M
Investing cash flow	BRL -1.4B
Net borrowing	BRL 1.6B
Net cash flow	BRL -6.7M
Net income	BRL -328M
Operating cash flow minus SBC	BRL -405M
Operating income	BRL -222.7M
Revenue	BRL 5.4B
Stock-based compensation	BRL 376.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.49
Book value per share	BRL 9.71
Debt / equity	5.67
Interest coverage	-4.89
Long-term assets	BRL 1.7B
Long-term liabilities	BRL 4B
Net cash (debt)	BRL -1.5B
Net cash / market cap	-19.95%
Net debt / equity	2.17
Piotroski F-Score	3
Property, plant and equipment	BRL 987.5M
Shareholders' equity	BRL 675.5M
Tangible book value	BRL 675.5M
Tangible book value per share	BRL 9.71
Total assets	BRL 6B
Total cash	BRL 2.4B
Total debt	BRL 3.8B
Total liabilities	BRL 5.3B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.03
Current assets	BRL 4.3B
Current liabilities	BRL 1.4B
Current ratio	3.18
Inventory turnover	3.3
Net working capital	BRL 600.5M
Quick ratio	2.44
Working capital	BRL 2.9B
Working capital turnover	11.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.08%
Shareholder yield	-3.08%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 6.69
1D price change	1.47%
1M price change	23.21%
1M total return	23.21%
1W price change	25.23%
1W total return	25.23%
1Y price change	28.25%
1Y return CAGR	28.28%
1Y total return	28.25%
20-day SMA	BRL 5.82
200-day SMA	BRL 6.38
3M price change	18.97%
3M total return	18.97%
50-day SMA	BRL 6.48
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 9.93
52-week high date	2026-02-23
52-week low	BRL 4.33
52-week low date	2026-05-18
6M price change	4.55%
6M total return	4.55%
All-time high	BRL 42.76
All-time high date	2022-02-09
All-time low	BRL 3.71
All-time low date	2025-08-11
Average true range (ATR)	BRL 0.29
Average volume	189.5
Change from 52-week high	-30.51%
Change from 52-week low	59.35%
Change from all-time high	-83.86%
Change from all-time low	85.98%
Change from open	0.44%
Day's gap	1.03%
Dollar volume	BRL 1,815
High price	BRL 6.90
Low price	BRL 6.83
Monthly RSI	41.42
Open price	BRL 6.87
Position in 52-week range	100%
Previous close	BRL 6.80
Price vs 150-day SMA	3.17%
Price vs 20-day SMA	18.54%
Price vs 200-day SMA	8.17%
Price vs 50-day SMA	6.47%
Relative volume	1.39
RSI	62.04
Sharpe ratio	0.52
Sortino ratio	0.96
Volume	263
Weekly RSI	50.33
YTD price change	-15.96%
YTD total return	-15.96%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	63.8M
Shares change (QoQ)	0.9%
Shares change (YoY)	3.08%
Shares held by insiders	1.01%
Shares held by institutions	108.39%
Short ratio	7.1 days

Deeper analysis on BVMF/T2ND34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/T2ND34 report

Is a complete BVMF/T2ND34 research report available?

No complete published report is available for bvmf/T2ND34 (BVMF/T2ND34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/T2ND34 (BVMF/T2ND34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/T2ND34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/T2ND34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/T2ND34

Frequently asked questions